NATHEALTH, the apex body representing the Indian healthcare industry, has announced the expansion of its Leadership Team for FY 2026–27 following its recent Governing Council meeting.

As part of this development, Shankha Banerjee, CEO of Dr. Lal Path Labs Ltd., has been appointed as Treasurer, and Mandeep Singh Kumar, Managing Director and Vice President of Medtronic India, has been appointed as Secretary.

They join the leadership team led by Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, who continues as President.

The expanded Leadership Team now comprises Dr Sangita Reddy as President, Himanshu Baid as Senior Vice President, Varun Khanna as Vice President, Shankha Banerjee as Treasurer, and Mandeep Singh Kumar as Secretary.

Siddhartha Bhattacharya will continue as Secretary General of NATHEALTH, leading the Secretariat’s efforts to build strategic partnerships, strengthen regional stakeholder engagement, and collaborate with policymakers to drive the next phase of healthcare development in India.

Welcoming the new appointments, President of NATHEALTH, Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, said, “We are delighted to welcome Mr. Shankha Banerjee and Mr. Mandeep Singh Kumar to the NATHEALTH Leadership Team. Both bring rich and diverse experience from across the healthcare ecosystem, diagnostics and pathology on one hand, and medical technology on the other, which will greatly strengthen our collective ability to drive meaningful change."

Secretary, NATHEALTH, Mandeep Singh Kumar, Managing Director & Vice President, Medtronic India said, “India’s healthcare ecosystem is at a pivotal moment, shaped by growing demand, evolving patient expectations, and rapid innovation. Building a future-ready system will require sustained investment in strong infrastructure, improved clinical outcomes, and scalable efficiency. Progress at this scale can only be achieved through deep collaboration across government, industry, and care providers. Medical technology has a critical role to play in advancing precision, expanding access, and enabling better outcomes for patients."

Treasurer, NATHEALTH, Shankha Banerjee, CEO, Dr. Lal Path Labs Ltd. said, “As the burden of non-communicable diseases continues to rise, there is a clear need to shift from reactive treatment to proactive and preventive care. Diagnostics will play a critical enabling role in this transition by supporting early detection and guiding clinical decisions. I look forward to contributing to NATHEALTH’s efforts to build a more integrated, efficient, and patient-centric healthcare ecosystem.”